Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors and antiviral drugs. Its rigid cyclopropane structure combined with the biphenyl group enhances binding selectivity and metabolic stability in drug candidates. Commonly employed in research for designing treatments targeting hepatitis C and other viral infections. Also utilized in the preparation of chiral amines for asymmetric synthesis in medicinal chemistry.